Evidence map›Paper›PMID 36517179›Full record

ArticleThe European respiratory journal2023

Development of a tool to detect small airways dysfunction in asthma clinical practice.

Janwillem Kocks, Thys van der Molen, Jaco Voorham, Simonetta Baldi, Maarten van den Berge, Chris Brightling, Leonardo M Fabbri, Monica Kraft, Gabriele Nicolini, Alberto Papi and 6 more

Open access · hybridAbstract read
In one paragraph

Article in The European respiratory journal, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.1field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Observational
  2. Review
  3. Review
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 9 institutions in 6 countries.

Janwillem KocksGeneral Practitioners Research Institute, Groningen, The Netherlands.
Thys van der MolenGeneral Practitioners Research Institute, Groningen, The Netherlands.
Jaco VoorhamDTIRS - Data to Insights Research Solutions, Lisboa, Portugal.
Simonetta BaldiInstitute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Maarten van den BergeUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute Asthma and COPD (GRIAC), Groningen, The Netherlands.
Chris BrightlingInstitute for Lung Health, NIHR Leicester Biomedical Research Centre, University of Leicester, Leicester, UK.
Leonardo M FabbriRespiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.ORCID 0000-0001-8894-1689
Monica KraftDepartment of Medicine, College of Medicine, and Asthma and Airway Disease Research Center, University of Arizona Health Sciences, Tucson, AZ, USA.
Gabriele NicoliniDepartment of Global Medical Affairs, Chiesi Farmaceutici S.p.A., Parma, Italy.
Alberto PapiRespiratory Medicine, Department of Translational Medicine, University of Ferrara, Ferrara, Italy.ORCID 0000-0002-6924-4500
Klaus F RabeLungenClinic Grosshansdorf and Department of Medicine, Christian Albrechts University, Member of the German Center for Lung Research (DZL), Kiel, Germany.
Salman SiddiquiNational Heart and Lung institute (NHLI), Imperial College, London, UK.
Dave SinghCentre for Respiratory Medicine and Allergy, Manchester University NHS Foundation Hospital Trust, University of Manchester, Manchester, UK.
Judith VonkUniversity of Groningen, University Medical Center Groningen, Groningen Research Institute Asthma and COPD (GRIAC), Groningen, The Netherlands.ORCID 0000-0001-7531-4547
Marika LevingGeneral Practitioners Research Institute, Groningen, The Netherlands.
Bertine Flokstra-de BlokGeneral Practitioners Research Institute, Groningen, The Netherlands bertine@gpri.nl.ORCID 0000-0001-5356-764X
University Medical Center Groningen · NLUniversity of Ferrara · ITUniversity of Leicester · GBChiesi (Italy) · ITGeneral Practitioners Research Institute · NLGerman Center for Lung Research · DELung Institute · USManchester University NHS Foundation Trust · GBUniversity of Arizona · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSmall airways dysfunction (SAD) in asthma is difficult to measure and a gold standard is lacking. The aim of this study was to develop a simple tool including items of the Small Airways Dysfunction Tool (SADT) questionnaire, basic patient characteristics and respiratory tests available depending on the clinical setting to predict SAD in asthma.

methodsThis study was based on the data of the multinational ATLANTIS (Assessment of Small Airways Involvement in Asthma) study including the earlier developed SADT questionnaire. Key SADT items together with clinical information were now used to build logistic regression models to predict SAD group (less likely or more likely to have SAD). Diagnostic ability of the models was expressed as area under the receiver operating characteristic curve (AUC) and positive likelihood ratio (LR+).

resultsSADT item 8, "I sometimes wheeze when I am sitting or lying quietly", and the patient characteristics age, age at asthma diagnosis and body mass index could reasonably well detect SAD (AUC 0.74, LR+ 2.3). The diagnostic ability increased by adding spirometry (percentage predicted forced expiratory volume in 1 s: AUC 0.87, LR+ 5.0) and oscillometry (resistance difference between 5 and 20 Hz and reactance area: AUC 0.96, LR+ 12.8).

conclusionsIf access to respiratory tests is limited (

Indexed as

AsthmaForced Expiratory VolumeHumansRespiratory Function TestsROC CurveSpirometry

Identifiers

PMID36517179
PMCPMC10060661
OpenAlexW4311432842

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.